Phair JP - Search Results

1

Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients.

Clerici M, Landay AL, Kessler HA, Phair JP, Venzon DJ, Hendrix CW, Lucey DR, Shearer GM. Clerici M, et al. Among authors: phair jp. J Infect Dis. 1992 Oct;166(4):723-30. doi: 10.1093/infdis/166.4.723. J Infect Dis. 1992. PMID: 1388195 Clinical Trial.

2

Suppression of cytomegalovirus retinitis in persons with AIDS with high-dose intravenous acyclovir.

Sha BE, Benson CA, Deutsch TA, Urbanski PA, Phair JP, Kessler HA. Sha BE, et al. Among authors: phair jp. J Infect Dis. 1991 Oct;164(4):777-80. doi: 10.1093/infdis/164.4.777. J Infect Dis. 1991. PMID: 1654361 Clinical Trial.

3

Predictors of outcome in AIDS patients receiving zidovudine.

Steinberg JP, Spear JB, Murphy RL, Wallemark CB, Benson CA, Kessler HA, Pottage JC Jr, Phair JP. Steinberg JP, et al. Among authors: phair jp. J Acquir Immune Defic Syndr (1988). 1989;2(3):229-34. J Acquir Immune Defic Syndr (1988). 1989. PMID: 2524583

4

Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Puhan MA, Van Natta ML, Palella FJ, Addessi A, Meinert C; Ocular Complications of AIDS Research Group. Puhan MA, et al. Clin Infect Dis. 2010 Oct 15;51(8):947-56. doi: 10.1086/656415. Clin Infect Dis. 2010. PMID: 20825306 Free PMC article.

5

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP. Landay AL, et al. Among authors: phair jp. AIDS Res Hum Retroviruses. 2002 Jan 20;18(2):95-102. doi: 10.1089/08892220252779638. AIDS Res Hum Retroviruses. 2002. PMID: 11839142 Clinical Trial.

6

Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time.

Farzadegan H, Chmiel JS, Odaka N, Ward L, Poggensee L, Saah A, Phair JP. Farzadegan H, et al. Among authors: phair jp. J Infect Dis. 1992 Dec;166(6):1217-22. doi: 10.1093/infdis/166.6.1217. J Infect Dis. 1992. PMID: 1358985

7

Prognostic value of combined response markers among human immunodeficiency virus-infected persons: possible aid in the decision to change zidovudine monotherapy.

Graham NM, Park LP, Piantadosi S, Phair JP, Mellors J, Fahey JL, Saah AJ. Graham NM, et al. Among authors: phair jp. Clin Infect Dis. 1995 Feb;20(2):352-62. doi: 10.1093/clinids/20.2.352. Clin Infect Dis. 1995. PMID: 7742442

8

Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring.

Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA. Hughes MD, et al. Among authors: phair jp. J Infect Dis. 1994 Jan;169(1):28-36. doi: 10.1093/infdis/169.1.28. J Infect Dis. 1994. PMID: 7903975 Clinical Trial.

9

Detection of infection with human immunodeficiency virus type 1 before seroconversion: correlation with clinical symptoms and outcome.

Phair JP, Margolick JB, Jacobson LP, Phillips J, Rinaldo C, Kaslow R, Chu C, Giorgi JV, Henrard D. Phair JP, et al. J Infect Dis. 1997 Apr;175(4):959-62. doi: 10.1086/514000. J Infect Dis. 1997. PMID: 9086159

10

Prognostic factors in human immunodeficiency virus-positive patients with a CD4+ lymphocyte count < 50/microL.

Apolonio EG, Hoover DR, He Y, Saah AJ, Lyter DW, Detels R, Kaslow RA, Phair JP. Apolonio EG, et al. Among authors: phair jp. J Infect Dis. 1995 Apr;171(4):829-36. doi: 10.1093/infdis/171.4.829. J Infect Dis. 1995. PMID: 7706809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters